Element Biosciences

Company profile

About Element Biosciences

Element Biosciences is a genomics technology company that develops integrated sequencing and multiomics platforms designed to empower the scientific community with greater freedom and flexibility in biological research. Founded by industry veterans, the company's mission is to provide high-quality sequencing without the premium pricing traditionally associated with next-generation sequencing platforms. Element's product portfolio includes the VITARI high-throughput sequencing platform, AVITI24 integrated multiomics system, AVITI mid-throughput sequencer, and AVITI LT focused sequencing system. All platforms are powered by the company's proprietary Avidite Base Chemistry (ABC) technology, which delivers highly accurate sequencing data with industry-leading quality scores exceeding 90% Q30 and up to 70% Q50+. The AVITI24 platform represents a significant innovation in the field, offering the first integrated system for sequencing, cell screening, and spatial profiling on a single benchtop instrument. It enables simultaneous analysis of DNA, RNA, proteins, phosphorylated proteins, and cell morphology from single samples without library preparation through Direct In Sample Sequencing (DISS) technology. Element serves diverse customer segments including academic research institutions, clinical laboratories, pharmaceutical companies, and agricultural biotechnology organizations. The company supports applications spanning whole genome sequencing, RNA sequencing, CRISPR screening, drug discovery, cancer research, and clinical diagnostics. With ISO 13485 certification achieved in 2026, Element is establishing a quality foundation for future diagnostic applications.

Company description · Element Biosciences official website

Mission. Our mission is to empower the scientific community with more freedom and flexibility to accelerate our collective impact on humanity.